If you are a member of the news media, an established news
blogger, or a news or feature producer seeking to develop a story
concerning a legal subject or newsworthy case, please visit our For The Media
PHILADELPHIA, Sept. 21 /PRNewswire/ -- Counsel for Plaintiffs in
the In re: Bally Total Fitness Securities Litigation class action
have announced the following:
UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF
ILLINOIS EASTERN DIVISION
PHILADELPHIA, Nov. 20 /PRNewswire-USNewswire/ -- Berger &
Montague, P.C. announces a tentativesettlement with JPMorgan Chase
and related companies that partially resolves a four-year-old
lawsuit accusing Chase and other credit card companies of...
PHILADELPHIA, March 16 /PRNewswire-USNewswire/ -- Berger &
Montague, P.C. has filed a class action lawsuit in the United
States Bankruptcy Court for the District of Delaware, Rieke, et al.
v. Monaco Coach Corporation, Civil Action No. 09-50444-KJC,...
On July 16, 2010, the Honorable Richard Stearns ruled that Plaintiff Carpenter's allegations of violations of the federal False Claims Act, 32 U.S.C. Section 3729(a)(1) arising from Abbott's alleged promotion of its AIDS drug Kaletra, for uses unapproved by the F.D.A., could proceed. Specifically, Plaintiff alleges that contrary to the F.D.A. approved uses and dosing for the drug, Abbott 1) promoted once daily dosing for therapy-experienced AIDS patients although such dosing was only approved for AIDS patients new to drug therapy and 2) promoted Kaletra as a single treatment regimen (monotherapy) rather than for use in combination with other anti-AIDS drugs. Simultaneously, the Court dismissed Plaintiff Carpenter's false claims allegations arising from alleged violations of the federal anti-kickback statute and Section (a)(2) of the False Claims Act. Discovery will now proceed in the case.
If You Purchased or Your Pet(s) Consumed Recalled Pet Food, You May Be Eligible To Participate in a Class Action Settlement
In 2010, Berger & Montague was named to the National Law Journal's "Plaintiff's Hot List" for the 7th time in 8 years. The NLJ designated the firm to it's Hall of Fame for having been recognized on the list in 2003-2005 and 2007-2010.
Berger & Montague, P.C., as lead counsel for the cardholder
classes in Ross, et al. v. Bank of America, N.A., et al.,
No. 05-cv-7116 (S.D.N.Y., Pauley, J.), has obtained final approval
of the first settlements nation-wide removing arbitration...
On February 24, 2010, Judge Douglas P. Woodlock of the U.S.
District Court in Boston denied the motion to dismiss filed by
Wyeth (now known as Pfizer). The case against Wyeth will now
proceed to discovery. Plaintiffs allege that Wyeth knowingly failed...
On July 15, the U.S. District Court in Massachusetts granted
motions allowing 19 additional states to join in the prosecution of
this whistleblower lawsuit against pharmaceutical company Wyeth,
Inc. (now known as Pfizer) that was filed by Berger &...
Berger & Montague, P.C., on behalf of cardholder classes, has reached tentative settlements with four credit card companies in a four-year-old lawsuit accusing six major credit card banks, and one arbitration provider, of unlawfully colluding to require cardholders to arbitrate disputes, including debt collections, and to preclude cardholders from participating in any class actions. The settling card companies are Chase, Bank of America, Capital One and HSBC. All settlements are subject to court approval. The lawsuit remains pending against Citibank, Discover and the National Arbitration Forum in the United States District Court for the Southern District of New York, as Ross, et al. v. Bank of America, N.A., et al., No. 05-cv-7116 and is a part of In re Currency Conversation Fee Antitrust Litigation, MDL No. 1409, in the same court.